Search hospitals > Connecticut > New Haven
Institute for Neurodegenerative Disorders
Claim this profileNew Haven, Connecticut 06510
Global Leader in Alzheimer's Disease
Global Leader in Parkinson's Disease
Conducts research for Dementia
Conducts research for Mild Cognitive Impairment
Conducts research for Multiple Sclerosis
70 reported clinical trials
1 medical researcher
Summary
Institute for Neurodegenerative Disorders is a medical facility located in New Haven, Connecticut. This center is recognized for care of Alzheimer's Disease, Parkinson's Disease, Dementia, Mild Cognitive Impairment, Multiple Sclerosis and other specialties. Institute for Neurodegenerative Disorders is involved with conducting 70 clinical trials across 21 conditions. There are 1 research doctors associated with this hospital, such as David Russell, M.D., Ph.D.Area of expertise
1Alzheimer's Disease
Global LeaderAPOE
ApoE positive
ApoE negative
2Parkinson's Disease
Global LeaderStage I
Stage II
Top PIs
Clinical Trials running at Institute for Neurodegenerative Disorders
Alzheimer's Disease
Mild Cognitive Impairment
Aducanumab
for Alzheimer's Disease
The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score as compared with placebo in participants with early Alzheimer's disease.
Recruiting1 award Phase 31 criteria
Remternetug
for Alzheimer's Disease
This trial tests remternetug, a drug given by injection or IV, in people with early Alzheimer's disease. It aims to find out if the drug is safe and can help improve symptoms or slow down the disease.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Institute for Neurodegenerative Disorders?
Institute for Neurodegenerative Disorders is a medical facility located in New Haven, Connecticut. This center is recognized for care of Alzheimer's Disease, Parkinson's Disease, Dementia, Mild Cognitive Impairment, Multiple Sclerosis and other specialties. Institute for Neurodegenerative Disorders is involved with conducting 70 clinical trials across 21 conditions. There are 1 research doctors associated with this hospital, such as David Russell, M.D., Ph.D.